Related Experiment Videos

Determining the requirements for a computer-based patient record with an electronic meeting system

C C Emery¹, L A Kian, M W Stewart

¹University of Texas Medical Center, Houston, USA.

Journal of the Society for Health Systems

|January 1, 1996

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled on pioglitazone, with or without metformin.

Diabetes, obesity & metabolism·2014

Autonomic neuropathy predisposes to rosiglitazone-induced vascular leakage in insulin-treated patients with type 2 diabetes: a randomised, controlled trial on thiazolidinedione-induced vascular leakage.

Diabetologia·2010

Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects.

Diabetes, obesity & metabolism·2009

Predicted biological activity of intravitreal VEGF Trap.

The British journal of ophthalmology·2008

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2007

Effect of metformin plus roziglitazone compared with metformin alone on glycaemic control in well-controlled Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2006

See all related articles